Treatment Strategies in Symptomatic Intermediate, Low-Risk, and Asymptomatic Patients With Severe Aortic Stenosis
Survival of symptomatic patients with severe aortic stenosis (AS) is very poor, with an average mortality reaching up to 2% per month. Approach to diagnosis and treatment of patients with AS was conservative; patients were referred to surgery only if the AS-induced symptoms become apparent and signi...
Ausführliche Beschreibung
Gespeichert in:
| Autor*in: |
Banovic, Marko D. [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
2018 |
|---|
| Umfang: |
20 |
|---|
| Übergeordnetes Werk: |
Enthalten in: Hepatic and intramyocellular glycogen stores in adults with type 1 diabetes and healthy controls - Bally, L. ELSEVIER, 2015, Chicago, Ill |
|---|---|
| Übergeordnetes Werk: |
volume:43 ; year:2018 ; number:8 ; pages:335-354 ; extent:20 |
| Links: |
|---|
| DOI / URN: |
10.1016/j.cpcardiol.2017.12.001 |
|---|
| Katalog-ID: |
ELV043669549 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | ELV043669549 | ||
| 003 | DE-627 | ||
| 005 | 20230624104629.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 180726s2018 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.cpcardiol.2017.12.001 |2 doi | |
| 028 | 5 | 2 | |a GBV00000000000292A.pica |
| 035 | |a (DE-627)ELV043669549 | ||
| 035 | |a (ELSEVIER)S0146-2806(17)30185-8 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | |a 610 | |
| 082 | 0 | 4 | |a 610 |q DE-600 |
| 082 | 0 | 4 | |a 610 |q VZ |
| 082 | 0 | 4 | |a 540 |q VZ |
| 084 | |a 35.40 |2 bkl | ||
| 100 | 1 | |a Banovic, Marko D. |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Treatment Strategies in Symptomatic Intermediate, Low-Risk, and Asymptomatic Patients With Severe Aortic Stenosis |
| 264 | 1 | |c 2018 | |
| 300 | |a 20 | ||
| 336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
| 337 | |a nicht spezifiziert |b z |2 rdamedia | ||
| 338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
| 520 | |a Survival of symptomatic patients with severe aortic stenosis (AS) is very poor, with an average mortality reaching up to 2% per month. Approach to diagnosis and treatment of patients with AS was conservative; patients were referred to surgery only if the AS-induced symptoms become apparent and significantly limit the quality of patient’ life. | ||
| 700 | 1 | |a Nikolic, Serge D. |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |n Yearbook Medical Publ |a Bally, L. ELSEVIER |t Hepatic and intramyocellular glycogen stores in adults with type 1 diabetes and healthy controls |d 2015 |g Chicago, Ill |w (DE-627)ELV023365331 |
| 773 | 1 | 8 | |g volume:43 |g year:2018 |g number:8 |g pages:335-354 |g extent:20 |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.cpcardiol.2017.12.001 |3 Volltext |
| 912 | |a GBV_USEFLAG_U | ||
| 912 | |a GBV_ELV | ||
| 912 | |a SYSFLAG_U | ||
| 912 | |a GBV_ILN_40 | ||
| 912 | |a GBV_ILN_651 | ||
| 936 | b | k | |a 35.40 |j Anorganische Chemie: Allgemeines |q VZ |
| 951 | |a AR | ||
| 952 | |d 43 |j 2018 |e 8 |h 335-354 |g 20 | ||
| 953 | |2 045F |a 610 | ||
| author_variant |
m d b md mdb |
|---|---|
| matchkey_str |
banovicmarkodnikolicserged:2018----:ramnsrtgeismtmtcnemdaeorsadsmtmtcain |
| hierarchy_sort_str |
2018 |
| bklnumber |
35.40 |
| publishDate |
2018 |
| allfields |
10.1016/j.cpcardiol.2017.12.001 doi GBV00000000000292A.pica (DE-627)ELV043669549 (ELSEVIER)S0146-2806(17)30185-8 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 540 VZ 35.40 bkl Banovic, Marko D. verfasserin aut Treatment Strategies in Symptomatic Intermediate, Low-Risk, and Asymptomatic Patients With Severe Aortic Stenosis 2018 20 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Survival of symptomatic patients with severe aortic stenosis (AS) is very poor, with an average mortality reaching up to 2% per month. Approach to diagnosis and treatment of patients with AS was conservative; patients were referred to surgery only if the AS-induced symptoms become apparent and significantly limit the quality of patient’ life. Nikolic, Serge D. oth Enthalten in Yearbook Medical Publ Bally, L. ELSEVIER Hepatic and intramyocellular glycogen stores in adults with type 1 diabetes and healthy controls 2015 Chicago, Ill (DE-627)ELV023365331 volume:43 year:2018 number:8 pages:335-354 extent:20 https://doi.org/10.1016/j.cpcardiol.2017.12.001 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U GBV_ILN_40 GBV_ILN_651 35.40 Anorganische Chemie: Allgemeines VZ AR 43 2018 8 335-354 20 045F 610 |
| spelling |
10.1016/j.cpcardiol.2017.12.001 doi GBV00000000000292A.pica (DE-627)ELV043669549 (ELSEVIER)S0146-2806(17)30185-8 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 540 VZ 35.40 bkl Banovic, Marko D. verfasserin aut Treatment Strategies in Symptomatic Intermediate, Low-Risk, and Asymptomatic Patients With Severe Aortic Stenosis 2018 20 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Survival of symptomatic patients with severe aortic stenosis (AS) is very poor, with an average mortality reaching up to 2% per month. Approach to diagnosis and treatment of patients with AS was conservative; patients were referred to surgery only if the AS-induced symptoms become apparent and significantly limit the quality of patient’ life. Nikolic, Serge D. oth Enthalten in Yearbook Medical Publ Bally, L. ELSEVIER Hepatic and intramyocellular glycogen stores in adults with type 1 diabetes and healthy controls 2015 Chicago, Ill (DE-627)ELV023365331 volume:43 year:2018 number:8 pages:335-354 extent:20 https://doi.org/10.1016/j.cpcardiol.2017.12.001 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U GBV_ILN_40 GBV_ILN_651 35.40 Anorganische Chemie: Allgemeines VZ AR 43 2018 8 335-354 20 045F 610 |
| allfields_unstemmed |
10.1016/j.cpcardiol.2017.12.001 doi GBV00000000000292A.pica (DE-627)ELV043669549 (ELSEVIER)S0146-2806(17)30185-8 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 540 VZ 35.40 bkl Banovic, Marko D. verfasserin aut Treatment Strategies in Symptomatic Intermediate, Low-Risk, and Asymptomatic Patients With Severe Aortic Stenosis 2018 20 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Survival of symptomatic patients with severe aortic stenosis (AS) is very poor, with an average mortality reaching up to 2% per month. Approach to diagnosis and treatment of patients with AS was conservative; patients were referred to surgery only if the AS-induced symptoms become apparent and significantly limit the quality of patient’ life. Nikolic, Serge D. oth Enthalten in Yearbook Medical Publ Bally, L. ELSEVIER Hepatic and intramyocellular glycogen stores in adults with type 1 diabetes and healthy controls 2015 Chicago, Ill (DE-627)ELV023365331 volume:43 year:2018 number:8 pages:335-354 extent:20 https://doi.org/10.1016/j.cpcardiol.2017.12.001 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U GBV_ILN_40 GBV_ILN_651 35.40 Anorganische Chemie: Allgemeines VZ AR 43 2018 8 335-354 20 045F 610 |
| allfieldsGer |
10.1016/j.cpcardiol.2017.12.001 doi GBV00000000000292A.pica (DE-627)ELV043669549 (ELSEVIER)S0146-2806(17)30185-8 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 540 VZ 35.40 bkl Banovic, Marko D. verfasserin aut Treatment Strategies in Symptomatic Intermediate, Low-Risk, and Asymptomatic Patients With Severe Aortic Stenosis 2018 20 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Survival of symptomatic patients with severe aortic stenosis (AS) is very poor, with an average mortality reaching up to 2% per month. Approach to diagnosis and treatment of patients with AS was conservative; patients were referred to surgery only if the AS-induced symptoms become apparent and significantly limit the quality of patient’ life. Nikolic, Serge D. oth Enthalten in Yearbook Medical Publ Bally, L. ELSEVIER Hepatic and intramyocellular glycogen stores in adults with type 1 diabetes and healthy controls 2015 Chicago, Ill (DE-627)ELV023365331 volume:43 year:2018 number:8 pages:335-354 extent:20 https://doi.org/10.1016/j.cpcardiol.2017.12.001 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U GBV_ILN_40 GBV_ILN_651 35.40 Anorganische Chemie: Allgemeines VZ AR 43 2018 8 335-354 20 045F 610 |
| allfieldsSound |
10.1016/j.cpcardiol.2017.12.001 doi GBV00000000000292A.pica (DE-627)ELV043669549 (ELSEVIER)S0146-2806(17)30185-8 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 540 VZ 35.40 bkl Banovic, Marko D. verfasserin aut Treatment Strategies in Symptomatic Intermediate, Low-Risk, and Asymptomatic Patients With Severe Aortic Stenosis 2018 20 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Survival of symptomatic patients with severe aortic stenosis (AS) is very poor, with an average mortality reaching up to 2% per month. Approach to diagnosis and treatment of patients with AS was conservative; patients were referred to surgery only if the AS-induced symptoms become apparent and significantly limit the quality of patient’ life. Nikolic, Serge D. oth Enthalten in Yearbook Medical Publ Bally, L. ELSEVIER Hepatic and intramyocellular glycogen stores in adults with type 1 diabetes and healthy controls 2015 Chicago, Ill (DE-627)ELV023365331 volume:43 year:2018 number:8 pages:335-354 extent:20 https://doi.org/10.1016/j.cpcardiol.2017.12.001 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U GBV_ILN_40 GBV_ILN_651 35.40 Anorganische Chemie: Allgemeines VZ AR 43 2018 8 335-354 20 045F 610 |
| language |
English |
| source |
Enthalten in Hepatic and intramyocellular glycogen stores in adults with type 1 diabetes and healthy controls Chicago, Ill volume:43 year:2018 number:8 pages:335-354 extent:20 |
| sourceStr |
Enthalten in Hepatic and intramyocellular glycogen stores in adults with type 1 diabetes and healthy controls Chicago, Ill volume:43 year:2018 number:8 pages:335-354 extent:20 |
| format_phy_str_mv |
Article |
| bklname |
Anorganische Chemie: Allgemeines |
| institution |
findex.gbv.de |
| dewey-raw |
610 |
| isfreeaccess_bool |
false |
| container_title |
Hepatic and intramyocellular glycogen stores in adults with type 1 diabetes and healthy controls |
| authorswithroles_txt_mv |
Banovic, Marko D. @@aut@@ Nikolic, Serge D. @@oth@@ |
| publishDateDaySort_date |
2018-01-01T00:00:00Z |
| hierarchy_top_id |
ELV023365331 |
| dewey-sort |
3610 |
| id |
ELV043669549 |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV043669549</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230624104629.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180726s2018 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.cpcardiol.2017.12.001</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBV00000000000292A.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV043669549</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0146-2806(17)30185-8</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">540</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">35.40</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Banovic, Marko D.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Treatment Strategies in Symptomatic Intermediate, Low-Risk, and Asymptomatic Patients With Severe Aortic Stenosis</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2018</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">20</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Survival of symptomatic patients with severe aortic stenosis (AS) is very poor, with an average mortality reaching up to 2% per month. Approach to diagnosis and treatment of patients with AS was conservative; patients were referred to surgery only if the AS-induced symptoms become apparent and significantly limit the quality of patient’ life.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Nikolic, Serge D.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Yearbook Medical Publ</subfield><subfield code="a">Bally, L. ELSEVIER</subfield><subfield code="t">Hepatic and intramyocellular glycogen stores in adults with type 1 diabetes and healthy controls</subfield><subfield code="d">2015</subfield><subfield code="g">Chicago, Ill</subfield><subfield code="w">(DE-627)ELV023365331</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:43</subfield><subfield code="g">year:2018</subfield><subfield code="g">number:8</subfield><subfield code="g">pages:335-354</subfield><subfield code="g">extent:20</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.cpcardiol.2017.12.001</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_651</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">35.40</subfield><subfield code="j">Anorganische Chemie: Allgemeines</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">43</subfield><subfield code="j">2018</subfield><subfield code="e">8</subfield><subfield code="h">335-354</subfield><subfield code="g">20</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
| author |
Banovic, Marko D. |
| spellingShingle |
Banovic, Marko D. ddc 610 ddc 540 bkl 35.40 Treatment Strategies in Symptomatic Intermediate, Low-Risk, and Asymptomatic Patients With Severe Aortic Stenosis |
| authorStr |
Banovic, Marko D. |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV023365331 |
| format |
electronic Article |
| dewey-ones |
610 - Medicine & health 540 - Chemistry & allied sciences |
| delete_txt_mv |
keep |
| author_role |
aut |
| collection |
elsevier |
| remote_str |
true |
| illustrated |
Not Illustrated |
| topic_title |
610 610 DE-600 610 VZ 540 VZ 35.40 bkl Treatment Strategies in Symptomatic Intermediate, Low-Risk, and Asymptomatic Patients With Severe Aortic Stenosis |
| topic |
ddc 610 ddc 540 bkl 35.40 |
| topic_unstemmed |
ddc 610 ddc 540 bkl 35.40 |
| topic_browse |
ddc 610 ddc 540 bkl 35.40 |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
zu |
| author2_variant |
s d n sd sdn |
| hierarchy_parent_title |
Hepatic and intramyocellular glycogen stores in adults with type 1 diabetes and healthy controls |
| hierarchy_parent_id |
ELV023365331 |
| dewey-tens |
610 - Medicine & health 540 - Chemistry |
| hierarchy_top_title |
Hepatic and intramyocellular glycogen stores in adults with type 1 diabetes and healthy controls |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)ELV023365331 |
| title |
Treatment Strategies in Symptomatic Intermediate, Low-Risk, and Asymptomatic Patients With Severe Aortic Stenosis |
| ctrlnum |
(DE-627)ELV043669549 (ELSEVIER)S0146-2806(17)30185-8 |
| title_full |
Treatment Strategies in Symptomatic Intermediate, Low-Risk, and Asymptomatic Patients With Severe Aortic Stenosis |
| author_sort |
Banovic, Marko D. |
| journal |
Hepatic and intramyocellular glycogen stores in adults with type 1 diabetes and healthy controls |
| journalStr |
Hepatic and intramyocellular glycogen stores in adults with type 1 diabetes and healthy controls |
| lang_code |
eng |
| isOA_bool |
false |
| dewey-hundreds |
600 - Technology 500 - Science |
| recordtype |
marc |
| publishDateSort |
2018 |
| contenttype_str_mv |
zzz |
| container_start_page |
335 |
| author_browse |
Banovic, Marko D. |
| container_volume |
43 |
| physical |
20 |
| class |
610 610 DE-600 610 VZ 540 VZ 35.40 bkl |
| format_se |
Elektronische Aufsätze |
| author-letter |
Banovic, Marko D. |
| doi_str_mv |
10.1016/j.cpcardiol.2017.12.001 |
| dewey-full |
610 540 |
| title_sort |
treatment strategies in symptomatic intermediate, low-risk, and asymptomatic patients with severe aortic stenosis |
| title_auth |
Treatment Strategies in Symptomatic Intermediate, Low-Risk, and Asymptomatic Patients With Severe Aortic Stenosis |
| abstract |
Survival of symptomatic patients with severe aortic stenosis (AS) is very poor, with an average mortality reaching up to 2% per month. Approach to diagnosis and treatment of patients with AS was conservative; patients were referred to surgery only if the AS-induced symptoms become apparent and significantly limit the quality of patient’ life. |
| abstractGer |
Survival of symptomatic patients with severe aortic stenosis (AS) is very poor, with an average mortality reaching up to 2% per month. Approach to diagnosis and treatment of patients with AS was conservative; patients were referred to surgery only if the AS-induced symptoms become apparent and significantly limit the quality of patient’ life. |
| abstract_unstemmed |
Survival of symptomatic patients with severe aortic stenosis (AS) is very poor, with an average mortality reaching up to 2% per month. Approach to diagnosis and treatment of patients with AS was conservative; patients were referred to surgery only if the AS-induced symptoms become apparent and significantly limit the quality of patient’ life. |
| collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U GBV_ILN_40 GBV_ILN_651 |
| container_issue |
8 |
| title_short |
Treatment Strategies in Symptomatic Intermediate, Low-Risk, and Asymptomatic Patients With Severe Aortic Stenosis |
| url |
https://doi.org/10.1016/j.cpcardiol.2017.12.001 |
| remote_bool |
true |
| author2 |
Nikolic, Serge D. |
| author2Str |
Nikolic, Serge D. |
| ppnlink |
ELV023365331 |
| mediatype_str_mv |
z |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| author2_role |
oth |
| doi_str |
10.1016/j.cpcardiol.2017.12.001 |
| up_date |
2024-07-06T19:25:58.964Z |
| _version_ |
1803858958314635264 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV043669549</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230624104629.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180726s2018 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.cpcardiol.2017.12.001</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBV00000000000292A.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV043669549</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0146-2806(17)30185-8</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">540</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">35.40</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Banovic, Marko D.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Treatment Strategies in Symptomatic Intermediate, Low-Risk, and Asymptomatic Patients With Severe Aortic Stenosis</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2018</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">20</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Survival of symptomatic patients with severe aortic stenosis (AS) is very poor, with an average mortality reaching up to 2% per month. Approach to diagnosis and treatment of patients with AS was conservative; patients were referred to surgery only if the AS-induced symptoms become apparent and significantly limit the quality of patient’ life.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Nikolic, Serge D.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Yearbook Medical Publ</subfield><subfield code="a">Bally, L. ELSEVIER</subfield><subfield code="t">Hepatic and intramyocellular glycogen stores in adults with type 1 diabetes and healthy controls</subfield><subfield code="d">2015</subfield><subfield code="g">Chicago, Ill</subfield><subfield code="w">(DE-627)ELV023365331</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:43</subfield><subfield code="g">year:2018</subfield><subfield code="g">number:8</subfield><subfield code="g">pages:335-354</subfield><subfield code="g">extent:20</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.cpcardiol.2017.12.001</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_651</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">35.40</subfield><subfield code="j">Anorganische Chemie: Allgemeines</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">43</subfield><subfield code="j">2018</subfield><subfield code="e">8</subfield><subfield code="h">335-354</subfield><subfield code="g">20</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
| score |
7.401043 |